Notopterol inhibits LPS-induced inflammation in BV-2 cells via AKT/Nrf2/HO-1 signaling axis
International Immunopharmacology · 2023
DOI: 10.1016/j.intimp.2023.110334 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Bojian Ye und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Lipopolysaccharides. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Accumulating research has indicated that inordinate activation of microglia releases inflammatory cytokines, damages neurons, and causes neuroinflammation, which eventually could lead to neurodegenerative diseases such as Parkinson's disease and Huntington's disease, etc. Notopterol (NOT) has anti-inflammatory and anti-oxidant functions in boundary tissues, but the effects of NOT on neuroinflammation have not been covered. Therefore, this study attempts to investigate the effect of NOT on neuroinflammation and the underlying mechanisms. According to the findings, NOT dramatically decreased the expression of pro-inflammatory mediators (interleukin-6 (IL-6), inducible nitric-oxide synthase (iNOS), tumor necrosis factor-α (TNF-α), and Cyclooxygenase-2 (COX-2)) in LPS-exposed BV-2 cells. Western blot analysis revealed that NOT could promote the activation of AKT/Nrf2/HO-1 signaling pathway. Further studies have shown that anti-inflammatory property of NOT was inhibited by MK2206 (an AKT inhibitor), RA (an Nrf2 inhibitor), and SnPP IX (an HO-1 inhibitor). In addition, it was also discovered that NOT could weaken the damage of LPS to BV-2 cells and improve their survival rate. As a result, our results imply that NOT inhibits the inflammatory response of BV-2 cells through the AKT/Nrf2/HO-1 signaling axis and exerts a neuroprotective effect by inhibiting the activation of BV-2 cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Jilin University, Changchun, China.
- College of Animal Science, Jilin University, Changchun, China.
- College of Animal Science, Jilin University, Changchun, China. Electronic address: hujp@jlu.edu.cn.
- College of Veterinary Medicine, Jilin University, Changchun, China. Electronic address: cuimc9920@mails.jlu.edu.cn.
- College of Veterinary Medicine, Jilin University, Changchun, China. Electronic address: lizhe9920@mails.jlu.edu.cn.
- College of Veterinary Medicine, Jilin University, Changchun, China. Electronic address: Wanghf9919@mails.jlu.edu.cn.
Förderung
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Ye, B., He, D., Hu, J., Yang, S., Gao, X., Cui, M., Li, Z., Wang, H., Huang, B., Fu, S., & Liu, D. (2023). Notopterol inhibits LPS-induced inflammation in BV-2 cells via AKT/Nrf2/HO-1 signaling axis. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110334
Vancouver
Ye B, He D, Hu J, Yang S, Gao X, Cui M, et al. Notopterol inhibits LPS-induced inflammation in BV-2 cells via AKT/Nrf2/HO-1 signaling axis. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110334
BibTeX
@article{Ye2023,
author = {Ye, Bojian and He, Dewei and Hu, Jinping and Yang, Shuo and Gao, Xiyu and Cui, Mingchi and Li, Zhe and Wang, Hefei and Huang, Bingxu and Fu, Shoupeng and Liu, Dianfeng},
title = {Notopterol inhibits LPS-induced inflammation in BV-2 cells via AKT/Nrf2/HO-1 signaling axis},
journal = {International Immunopharmacology},
year = {2023},
doi = {10.1016/j.intimp.2023.110334}
}
EUVIMED